US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 47.240
  • +1.220+2.65%
Close Nov 22 16:00 ET
  • 47.240
  • 0.0000.00%
Post 20:01 ET
4.36BMarket Cap-7439P/E (TTM)

About Ultragenyx Pharmaceutical Company

Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010, and is headquartered in Novato, CA.

Company Profile

SymbolRARE
Company NameUltragenyx Pharmaceutical
Listing DateJan 31, 2014
Issue Price21.00
Founded2010
CEODr. Emil D. Kakkis, M.D.,PhD
MarketNASDAQ
Employees1276
Fiscal Year Ends12-31
Address60 Leveroni Court
CityNovato
ProvinceCalifornia
CountryUnited States of America
Zip Code94949
Phone1-415-483-8800
Websitehttp://www.ultragenyx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Emil D. Kakkis, M.D.,PhD
  • Director, President, Chief Executive Officer
  • 13.08M
  • John Richard Pinion, II
  • Chief Quality Officer and Executive Vice President, Translational Sciences
  • 4.05M
  • Howard Horn
  • Chief Financial Officer and Executive Vice President, Corporate Strategy
  • 5.94M
  • Karah Parschauer
  • Chief Legal Officer and Executive Vice President, Corporate Affairs
  • 4.04M
  • Thomas R. Kassberg
  • Chief Business Officer and Executive Vice President
  • --
  • Dr. Eric Crombez, M.D.
  • Executive Vice President and Chief Medical Officer
  • --
  • Erik Harris
  • Chief Commercial Officer and Executive Vice President
  • 4.07M
  • Dennis Karl Huang
  • Chief Technical Operations Officer and Executive Vice President, Gene Therapy Operations
  • --
  • Theodore A. Huizenga
  • Senior Vice President, Corporate Controller and Chief Accounting Officer
  • --
  • Daniel G. Welch
  • Chairman of the Board
  • 499.89K
  • Dr. Shehnaaz Suliman, M.D.
  • Independent Director
  • 466.89K
  • Dr. Corazon Dating Sanders, PhD
  • Independent Director
  • 469.39K
  • Dr. Deborah L. Dunsire,M.D.
  • Independent Director
  • 459.89K
  • Dr. Amrit Ray, M.D.
  • Independent Director
  • 460.39K
  • Michael A. Narachi
  • Independent Director
  • 482.39K
  • Matthew K. Fust
  • Independent Director
  • 479.89K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data